A critical assessment of treatment options for idiopathic pulmonary fibrosis.

[1]  Zhen-hua Li.  [The treatment of idiopathic pulmonary fibrosis]. , 2007, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.

[2]  D. G. Morris,et al.  TIME WILL TELL , 2020, The Ancient Way.

[3]  G. Raghu,et al.  A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. , 2004, The New England journal of medicine.

[4]  L. Laine,et al.  Guidelines for the appropriate use of non‐steroidal anti‐inflammatory drugs, cyclo‐oxygenase‐2‐specific inhibitors and proton pump inhibitors in patients requiring chronic anti‐inflammatory therapy , 2004, Alimentary pharmacology & therapeutics.

[5]  D. G. Morris,et al.  Time will tell: predicting survival in idiopathic interstitial pneumonia. , 2003, American journal of respiratory and critical care medicine.

[6]  S. Nagai,et al.  Open-label compassionate use one year-treatment with pirfenidone to patients with chronic pulmonary fibrosis. , 2002, Internal medicine.

[7]  S. Swetter,et al.  Developing indications for the use of sentinel lymph node biopsy and adjuvant high-dose interferon alfa-2b in melanoma. , 2001, Archives of dermatology.

[8]  L. Altshuler,et al.  The Expert Consensus Guideline Series. Treatment of depression in women. , 2001, Postgraduate medicine.

[9]  B. Burnand,et al.  Appropriateness of Surgery for Sciatica: Reliability of Guidelines From Expert Panels , 2000, Spine.

[10]  D. Schroeder,et al.  Idiopathic pulmonary fibrosis: Impact of oxygen and colchicine, prednisone, or no therapy on survival. , 2000, American journal of respiratory and critical care medicine.

[11]  David A. Lynch,et al.  Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .

[12]  V. Petkov,et al.  A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. , 1999, The New England journal of medicine.

[13]  M. Kitaichi,et al.  Hospital-based historical cohort study of 234 histologically proven Japanese patients with IPF. , 1999, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[14]  G. Raghu,et al.  Treatment of Idiopathic Pulmonary Fibrosis with a New Antifibrotic Agent , Pirfenidone Results of a Prospective , Open-label Phase II Study , 1999 .

[15]  R. Chapela,et al.  Colchicine, D-penicillamine, and prednisone in the treatment of idiopathic pulmonary fibrosis: a controlled clinical trial. , 1998, Chest.

[16]  S. Swensen,et al.  Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Members of the Lung Study Group. , 1998, American journal of respiratory and critical care medicine.

[17]  D. Gupta,et al.  Response to steroid therapy in patients of idiopathic pulmonary fibrosis: a retrospective analysis. , 1998, The Indian journal of chest diseases & allied sciences.

[18]  M A Schork,et al.  Idiopathic pulmonary fibrosis: predicting response to therapy and survival. , 1998, American journal of respiratory and critical care medicine.

[19]  G. Raghu,et al.  Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. , 1991, The American review of respiratory disease.

[20]  J. Darbyshire,et al.  Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. , 1989, Thorax.

[21]  K. Kahn,et al.  Physician ratings of appropriate indications for six medical and surgical procedures. , 1986, American journal of public health.

[22]  B. Burrows,et al.  Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival , 1980, Thorax.